NCT00847678View on ClinicalTrials.gov

Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS

PHASE2TerminatedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

November 30, 2007

Conditions
Cryptococcal Meningitis
Interventions
BIOLOGICAL

Efungumab (Mycograb)

BIOLOGICAL

placebo

BIOLOGICAL

Amphotericin B

BIOLOGICAL

5 flucytosine

Trial Locations (1)

Unknown

Novartis Investigative Site, South Africa

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY